Alesta Therapeutics
Developer of small-molecule biotech program designed for the development of innovative therapies targeting synthetic lethal metabolic dependencies in cancer. The company targets a control mechanism in...
Valuation
$0
Share Price
N/A
Total Raised
$68.3M
Last Round
N/A